160939-10-6

Basic information

• Product Name: 6-(AMINOMETHYL)-2-PYRIDINE CARBOXYLIC ACID
• Synonyms: 6-(AMINOMETHYL)-2-PYRIDINE CARBOXYLIC ACID;6-AMINOMETHYL-PYRIDINE-2-CARBOXYLIC ACID;2-Pyridinecarboxylicacid,6-(aminomethyl)-,methylester(9CI);METHYL 6-(AMINOMETHYL)PICOLINATE;6-Aminomethyl-pyridine-2-carboxylic acid methyl ester;6-(Aminomethyl)-2-pyridine carboxylic acid ,97%;Methyl 6-(aMinoMethyl)pyridine-2-carboxylate;6-(AMinoMethyl)picolinic acid
• CAS NO: 160939-10-6
• Molecular Formula: C7H8N2O2
• Molecular Weight: 152.15
• Product Categories: GLYCINESCAFFOLD;Pyridine series
• Mol File: 160939-10-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 352.407 °C at 760 mmHg
• Flash Point: 166.93 °C
• Appearance: /
• Density: 1.321 g/cm³
• Vapor Pressure: 1.42E-05mmHg at 25°C
• Refractive Index: 1.606
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 8.43±0.39(Predicted)
• CAS DataBase Reference: 6-(AMINOMETHYL)-2-PYRIDINE CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(AMINOMETHYL)-2-PYRIDINE CARBOXYLIC ACID(160939-10-6)
• EPA Substance Registry System: 6-(AMINOMETHYL)-2-PYRIDINE CARBOXYLIC ACID(160939-10-6)

Safety Data

• Hazardous Substances Data: 160939-10-6(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C7H8N2O2/c8-4-5-2-1-3-6(9-5)7(10)11/h1-3H,4,8H2,(H,10,11)

Upstream product

• 1121-60-4 pyridine-2-carbaldehyde 
• 77-92-9 citric acid 
• 108-48-5 2,6-dimethylpyridine 
• 934-60-1 6-methyl-2-pyridinecarboxylic acid 
• 13602-11-4 6-methylpicolinic acid methyl ester 
• 146462-25-1 methyl 6-(bromomethyl)picolinate 
• 5453-67-8 2,6-bis(methoxycarbonyl)pyridine 
• 39977-44-1 methyl 6-(hydroxymethyl)pyridine-2-carboxylate 

Downstream Products

• 171670-07-8 6-{[(tertbutoxycarbonyl)amino]methyl}-2-pyridinecarboxylic acid 

Relevant articles and documents

CHELATORS AND METHODS OF MAKING AND USING SAME

A chelating agent having the general formula (I) is provided (I) Metal chelates and constructs for carrying out targeted radionuclide therapy incorporating such chelating agents are provided. Methods of making and using the chelating agent, metal chelates and constructs for carrying out targeted radionuclide therapy, as well as diagnostic and therapeutic methods using such constructs, are provided.

Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIB/IIIA

This invention relates to novel cyclic compounds linked by a heterocyclic ring system, which are useful as antagonists of the platelet glycoprotein IIb/IIIa complex, to pharmaceutical compositions containing such cyclic compounds, and to methods of using these compounds for the inhibition of platelet aggregation. A representative compound of the invention is cyclo-(D-Val-N(Me)Arg-Gly-Asp-?5-aminomethyl!-2-furoate).